Results 201 to 210 of about 10,634,853 (332)

Promising Vaccine Formulations for Emerging Infectious Diseases. [PDF]

Int J Mol Sci
Park PG, Lee SY, Youn H, Hong KJ.
europepmc   +1 more source

Analysis of the Longitudinal Behavior of Serum Levels of Soluble Flt1 and Placental Growth Factor in Pregnant Patients With Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective This study analyzed longitudinal trajectories of soluble Flt1 (sFlt1) levels, placenta growth factor (PlGF) levels, and sFlt1:PlGF ratios in a cohort of pregnant patients with systemic lupus erythematosus (SLE). Methods Blood samples were collected (14–18, 24–26, 30–32, 34–36, and 38–40 weeks), stored at −80°C, and evaluated for serum levels ...
Nilson R. de Jesús, Guilherme R. de Jesús, Marcela I. Lacerda, Flávia C. dos Santos, Jeane de S Nogueira, Luiz Cristóvão Porto, Evandro S. F. Coutinho, Evandro M. Klumb   +7 more
wiley   +1 more source

Animal models of oral infectious diseases. [PDF]

Front Oral Health
Li J, Zhao YN, Wang YH, Chen Y, Hou JL, Wang DY, Shi L, Shen J.   +7 more
europepmc   +1 more source

INFECTION AND IMMUNITY, WITH SPECIAL REFERENCE TO THE PREVENTION OF INFECTIOUS DISEASES

, 1904
GEORGE M. STERNBERG
openalex   +2 more sources

Metabolic Consequences of Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Patients with rheumatoid arthritis (RA) may have metabolic disruption, which can contribute to adverse long‐term outcomes, for multiple reasons. Patients with RA appear to have a higher risk of sarcopenia, type 1 and type 2 diabetes mellitus, metabolic syndrome, and hypertension. Systemic inflammation in RA can cause a “lipid paradox,” with reduced low‐
Stevie Barry, Emily Sheng, Joshua F. Baker   +2 more
wiley   +1 more source

A data-driven financial justification for an outpatient infectious diseases pharmacist. [PDF]

Antimicrob Steward Healthc Epidemiol
Kim JJ, Hernandez Guarin LN, Contreras J, Hayden MK, Won SY.   +4 more
europepmc   +1 more source

Discussion on Nutrition and its Effects on Infectious Disease [PDF]

, 1937

openalex   +1 more source

Gastrointestinal Perforation as a Safety Concern Among Patients With Rheumatoid Arthritis Receiving JAK Inhibitor Therapy: A Systematic Review and Network Meta‐Analysis

Arthritis Care &Research, EarlyView.
Objective Gastrointestinal perforation (GIP) is a rare and life‐threatening safety concern associated with JAK inhibitors (JAKi). We aimed to review the evidence regarding the risk of GIP associated with the use of JAKi in patients with rheumatoid arthritis (RA) using a systematic review and network meta‐analysis approach.
Thipsukhon Sathapanasiri, Manuel Meraz, Hamraz Mokri, Sajesh K Veettil, Karn Wijarnpreecha, Naomi Schlesinger, Arthur Kavanaugh, Nathorn Chaiyakunapruk   +7 more
wiley   +1 more source

Bacteriophage-based strategies for biocontrol and treatment of infectious diseases. [PDF]

Comput Struct Biotechnol J
Thi Trang Nhung T, Verma S, Ponne S, Meghwanshi GK, Schön T, Kumar R.   +5 more
europepmc   +1 more source

ON THE EARLY DETECTION OF INFECTIOUS DISEASES. [PDF]

Robert J. Farquharson
openalex   +1 more source